Skip to main content
Erschienen in: Odontology 1/2024

16.05.2023 | Original Article

Immunoexpression of SIRT1, 6, and 7 in oral leukoplakia and oral squamous cell carcinoma

verfasst von: Pawat Sripodok, Haruka Saito, Atsumu Kouketsu, Tetsu Takahashi, Hiroyuki Kumamoto

Erschienen in: Odontology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Sirtuins (SIRTs) are a family of proteins involved in the metabolic process responsible for extending the lifespan. The role of SIRT1, 6, and 7 in oral squamous cell carcinoma (OSCC) and oral leukoplakia (OLP), one of its precursors, is still elusive. In this study, 82 OLP and 77 OSCC were immunohistochemically examined for SIRT1, 6, and 7. Stained sections were thoroughly scanned and evaluated using a digital image analysis program. The SIRT1, 6, and 7 expressions were detected in the nuclei of epithelial and carcinoma cells in various degrees. Afterward, any correlations among SIRTs, including associations with clinicopathological features and the Kaplan–Meier curves were analyzed. OSCC demonstrated significantly higher SIRT1 expression than OLP, while non-dysplastic lesions showed significantly higher SIRT6 expression than other lesions. A strong correlation was observed between SIRT6 and 7 in OLP, SIRT1 and 6 in in OSCC and in SIRT6 and 7 when all lesion types were considered. There were no significant differences between SIRTs reactivity and the clinical features in OLP. For OSCC, SIRT1 and 6 was found to be directly associated with site of the lesion, while SIRT7 showed a direct relationship between gender, stromal lymphocytic infiltration, and depth of the invasion. OSCC with high SIRT7 expression revealed a slightly lower survival probability, although not statistically significant (p = 0.1019). Our findings suggest that SIRT1, 6, and 7 may play correlated and diverse roles in the development and advancement of OSCC.
Literatur
1.
Zurück zum Zitat Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim [Internet]. 2020;6:92.CrossRefPubMed Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim [Internet]. 2020;6:92.CrossRefPubMed
2.
Zurück zum Zitat El-Naggar AK, JKC C, Grandis JR, Takata T, Grandis J, Slootweg P, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017. El-Naggar AK, JKC C, Grandis JR, Takata T, Grandis J, Slootweg P, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017.
4.
Zurück zum Zitat Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2018;125:582–90.CrossRefPubMed Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2018;125:582–90.CrossRefPubMed
5.
Zurück zum Zitat Zhao L, Cao J, Hu K, He X, Yun D, Tong T, et al. Sirtuins and their biological relevance in aging and age-related diseases. Aging Dis. 2020;11:927–45.CrossRefPubMedPubMedCentral Zhao L, Cao J, Hu K, He X, Yun D, Tong T, et al. Sirtuins and their biological relevance in aging and age-related diseases. Aging Dis. 2020;11:927–45.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Islam S, Abiko Y, Uehara O, Chiba I. Sirtuin 1 and oral cancer. Oncol Lett [Internet]. 2019;17:729–38.PubMed Islam S, Abiko Y, Uehara O, Chiba I. Sirtuin 1 and oral cancer. Oncol Lett [Internet]. 2019;17:729–38.PubMed
7.
Zurück zum Zitat Roth M, Chen WY. Sorting out functions of sirtuins in cancer. Oncogene [Internet]. 2014;33:1609–20.CrossRefPubMed Roth M, Chen WY. Sorting out functions of sirtuins in cancer. Oncogene [Internet]. 2014;33:1609–20.CrossRefPubMed
8.
Zurück zum Zitat Carafa V, Altucci L, Nebbioso A. Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Front Pharmacol [Internet]. 2019;10:38.CrossRefPubMed Carafa V, Altucci L, Nebbioso A. Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Front Pharmacol [Internet]. 2019;10:38.CrossRefPubMed
9.
Zurück zum Zitat Palmirotta R, Cives M, Della-Morte D, Capuani B, Lauro D, Guadagni F, et al. Sirtuins and cancer: Role in the epithelial-mesenchymal transition. Oxid Med Cell Longev [Internet]. 2016;2016:3031459.PubMed Palmirotta R, Cives M, Della-Morte D, Capuani B, Lauro D, Guadagni F, et al. Sirtuins and cancer: Role in the epithelial-mesenchymal transition. Oxid Med Cell Longev [Internet]. 2016;2016:3031459.PubMed
10.
Zurück zum Zitat Behnisch-Cornwell S, Grathwol CW, Schulig L, Voigt A, Baecker D, Link A, et al. Correlation analysis of protein expression of 10 HDAC/Sirtuin isoenzymes with sensitivities of 23 anticancer drugs in 17 cancer cell lines and potentiation of drug activity by co-treatment with HDAC inhibitors. Cancers (Basel) [Internet]. 2021;14:187.CrossRefPubMedCentral Behnisch-Cornwell S, Grathwol CW, Schulig L, Voigt A, Baecker D, Link A, et al. Correlation analysis of protein expression of 10 HDAC/Sirtuin isoenzymes with sensitivities of 23 anticancer drugs in 17 cancer cell lines and potentiation of drug activity by co-treatment with HDAC inhibitors. Cancers (Basel) [Internet]. 2021;14:187.CrossRefPubMedCentral
11.
Zurück zum Zitat Siril YJ, Kouketsu A, Oikawa M, Takahashi T, Kumamoto H. Immunohistochemical assessment of chromatin licensing and DNA replication factor 1, geminin, and gamma-H2A.X in oral epithelial precursor lesions and squamous cell carcinoma. J Oral Pathol Med [Internet]. 2019;48:888–96.CrossRefPubMed Siril YJ, Kouketsu A, Oikawa M, Takahashi T, Kumamoto H. Immunohistochemical assessment of chromatin licensing and DNA replication factor 1, geminin, and gamma-H2A.X in oral epithelial precursor lesions and squamous cell carcinoma. J Oral Pathol Med [Internet]. 2019;48:888–96.CrossRefPubMed
12.
Zurück zum Zitat Brierley JD, Gospodarowickz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: Wiley Blackwell; 2017. Brierley JD, Gospodarowickz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. Oxford: Wiley Blackwell; 2017.
13.
Zurück zum Zitat Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg [Internet]. 1984;6:938–47.CrossRefPubMed Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg [Internet]. 1984;6:938–47.CrossRefPubMed
14.
Zurück zum Zitat Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep [Internet]. 2017;7:16878.CrossRefPubMed Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep [Internet]. 2017;7:16878.CrossRefPubMed
15.
Zurück zum Zitat Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13:2580.CrossRef Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13:2580.CrossRef
16.
Zurück zum Zitat Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227.CrossRefPubMed Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227.CrossRefPubMed
18.
Zurück zum Zitat Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer [Internet]. 2014;13:254.CrossRefPubMed Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer [Internet]. 2014;13:254.CrossRefPubMed
19.
Zurück zum Zitat Kang YY, Sun FL, Zhang Y, Wang Z. SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma. J Chin Med Assoc [Internet]. 2018;81:416–22.CrossRefPubMed Kang YY, Sun FL, Zhang Y, Wang Z. SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma. J Chin Med Assoc [Internet]. 2018;81:416–22.CrossRefPubMed
20.
Zurück zum Zitat Lu CT, Hsu CM, Lin PM, Lai CC, Lin HC, Yang CH, et al. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma. Anticancer Res [Internet]. 2014;34:7137–43.PubMed Lu CT, Hsu CM, Lin PM, Lai CC, Lin HC, Yang CH, et al. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma. Anticancer Res [Internet]. 2014;34:7137–43.PubMed
21.
Zurück zum Zitat Jia B, Zhang S, Wu S, Zhu Q, Li W. MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway. IUBMB Life [Internet]. 2021;73:264–72.CrossRefPubMed Jia B, Zhang S, Wu S, Zhu Q, Li W. MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway. IUBMB Life [Internet]. 2021;73:264–72.CrossRefPubMed
22.
Zurück zum Zitat Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML, et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol [Internet]. 2013;34:1847–54.CrossRefPubMed Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML, et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol [Internet]. 2013;34:1847–54.CrossRefPubMed
23.
Zurück zum Zitat Yoshii H, Sekihara K, Ideta Y, Nakajima S, Kato I, Okubo-Sato M, et al. The expression of SIRT6 is associated with treatment outcome in elder patients with oral cancer. Anticancer Res. 2022;42:3815–23.CrossRefPubMed Yoshii H, Sekihara K, Ideta Y, Nakajima S, Kato I, Okubo-Sato M, et al. The expression of SIRT6 is associated with treatment outcome in elder patients with oral cancer. Anticancer Res. 2022;42:3815–23.CrossRefPubMed
24.
Zurück zum Zitat Li W, Zhu D, Qin S. SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation. J Exp Clin Cancer Res [Internet]. 2018;37:148.CrossRefPubMed Li W, Zhu D, Qin S. SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation. J Exp Clin Cancer Res [Internet]. 2018;37:148.CrossRefPubMed
25.
Zurück zum Zitat Hu A, Huang JJ, Li RL, Lu ZY, Duan JL, Xu WH, et al. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1. Sci Rep [Internet]. 2015;5:13429.CrossRefPubMed Hu A, Huang JJ, Li RL, Lu ZY, Duan JL, Xu WH, et al. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1. Sci Rep [Internet]. 2015;5:13429.CrossRefPubMed
26.
Zurück zum Zitat Islam S, Uehara O, Matsuoka H, Kuramitsu Y, Adhikari BR, Hiraki D, et al. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing—a possible predictive biomarker for malignant transformation. Clin Epigenet. 2020;12:1–10.CrossRef Islam S, Uehara O, Matsuoka H, Kuramitsu Y, Adhikari BR, Hiraki D, et al. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing—a possible predictive biomarker for malignant transformation. Clin Epigenet. 2020;12:1–10.CrossRef
27.
Zurück zum Zitat Lee HJ, Auh QS, Lee YM, Kang SK, Chang SW, Lee DS, et al. Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-kappaB, and SIRT1 signaling pathway. Planta Med [Internet]. 2013;79:1298–306.CrossRefPubMed Lee HJ, Auh QS, Lee YM, Kang SK, Chang SW, Lee DS, et al. Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-kappaB, and SIRT1 signaling pathway. Planta Med [Internet]. 2013;79:1298–306.CrossRefPubMed
28.
Zurück zum Zitat Murofushi T, Tsuda H, Mikami Y, Yamaguchi Y, Suzuki N. CAY10591, a SIRT1 activator, suppresses cell growth, invasion, and migration in gingival epithelial carcinoma cells. J Oral Sci [Internet]. 2017;59:415–23.CrossRefPubMed Murofushi T, Tsuda H, Mikami Y, Yamaguchi Y, Suzuki N. CAY10591, a SIRT1 activator, suppresses cell growth, invasion, and migration in gingival epithelial carcinoma cells. J Oral Sci [Internet]. 2017;59:415–23.CrossRefPubMed
29.
Zurück zum Zitat Park JJ, Hah YS, Ryu S, Cheon SY, Won SJ, Lee JS, et al. MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers. Exp Mol Med [Internet]. 2021;53:422–31.CrossRefPubMed Park JJ, Hah YS, Ryu S, Cheon SY, Won SJ, Lee JS, et al. MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers. Exp Mol Med [Internet]. 2021;53:422–31.CrossRefPubMed
30.
Zurück zum Zitat Langsfeld ES, Bodily JM, Laimins LA. The deacetylase sirtuin 1 regulates human papillomavirus replication by modulating histone acetylation and recruitment of DNA damage factors NBS1 and Rad51 to viral genomes. PLOS Pathog. 2015;11:1–21.CrossRef Langsfeld ES, Bodily JM, Laimins LA. The deacetylase sirtuin 1 regulates human papillomavirus replication by modulating histone acetylation and recruitment of DNA damage factors NBS1 and Rad51 to viral genomes. PLOS Pathog. 2015;11:1–21.CrossRef
31.
Zurück zum Zitat Allison J, Jiang M, Milner J. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging. 2009;1:316–27.CrossRefPubMedPubMedCentral Allison J, Jiang M, Milner J. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging. 2009;1:316–27.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kikuchi K, Noguchi A, Kasajima R, Miyagi Y, Hoshino D, Koshikawa N, et al. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma. Tumour Biol [Internet]. 2015;36:7865–72.CrossRefPubMed Kikuchi K, Noguchi A, Kasajima R, Miyagi Y, Hoshino D, Koshikawa N, et al. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma. Tumour Biol [Internet]. 2015;36:7865–72.CrossRefPubMed
33.
Zurück zum Zitat Noguchi A, Li X, Kubota A, Kikuchi K, Kameda Y, Zheng H, et al. SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2013;115:385–92.CrossRefPubMed Noguchi A, Li X, Kubota A, Kikuchi K, Kameda Y, Zheng H, et al. SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2013;115:385–92.CrossRefPubMed
Metadaten
Titel
Immunoexpression of SIRT1, 6, and 7 in oral leukoplakia and oral squamous cell carcinoma
verfasst von
Pawat Sripodok
Haruka Saito
Atsumu Kouketsu
Tetsu Takahashi
Hiroyuki Kumamoto
Publikationsdatum
16.05.2023
Verlag
Springer Nature Singapore
Erschienen in
Odontology / Ausgabe 1/2024
Print ISSN: 1618-1247
Elektronische ISSN: 1618-1255
DOI
https://doi.org/10.1007/s10266-023-00816-x

Weitere Artikel der Ausgabe 1/2024

Odontology 1/2024 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.